Scientists in Israel have been able to transmute skin cells into working heart cells. This method is derived from the use of human-induced pluripotent stem cells or hiPSCs, which are an alternative to embryonic stem cells. Imagine an old man being given a heart that has the same power as his own from when he was a child, without the need for drugs to prevent graft rejection which carry their own risks of significant morbidity. This is a fantastic breakthrough, considering the global burden of heart disease with cardiac-related deaths reaching 216 per 100,000 people in some areas.
Professor Lior Gepstein, professor of cardiology and physiology at the Technion-Israel Institute of Technology in Haifa however acknowledged that this method is still far off from everyday use in humans although clinical trials should begin in five to ten years.